Skip to content

To evaluate the efficacy of Haridra yashtimadhu kumari lepa in the management of mukhapaka with special reference to inflammatory oral mucosal conditions

A randomized open labelled controlled clinical study to evaluate the efficacy of haridra yashtimadhu kumari lepa in the management of mukhapaka with special reference to inflammatory oral mucosal conditions

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048527
Enrollment
30
Registered
2022-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K121- Other forms of stomatitis

Interventions

None listed

Sponsors

Dr Sheethal S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects aged between 21 to 60 years irrespective of gender, occupation, religion and socio-economic status. 2.Subjects fulfilling the diagnostic criteria. 3.Subjects willing to sign the informed consent. 4.Subjects under Immunomodulatory medications.

Exclusion criteria

Exclusion criteria: 1.Subjects having Mukhapaka due to necrosis or sublingual Abscess. 2.Subjects with other oral lesions due to systemic diseases. 3.Subjects who are under any other treatments for Mukhapaka.

Design outcomes

Primary

MeasureTime frame
Reduction in signs and symptoms of Mukhapaka w.s.r to Inflammatory Oral Mucosal Conditions on the basis of favorable changes in the overall assessment criteria.Timepoint: 0th day - Before treatment 3rd day - During treatment 7th day - After treatment 14th day - Follow up 1 21st day - Follow up 2 28th day - Follow up 3

Secondary

MeasureTime frame
1.Ruja (Pain) 2.Daha (Burning sensation) 3.Kruchra mukha vivranata(Difficulty in opening mouth) 4.Size of Mukhapaka (Measurement with vernier calipers) 5.Raga (Redness) 6.Shopha (swelling)Timepoint: 0th day - Before treatment 3rd day - During treatment 7th day - After treatment 14th day - Follow up 1 21st day - Follow up 2 28th day - Follow up 3

Countries

India

Contacts

Public ContactDr Sheethal S

Sri Sri College of Ayurvedic Science and Research Hospital

ayurgeeta@gmail.com9480056218

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026